Screening Program Calculator: Zero to Hero Tutorial

This tutorial takes you from screening principles through test performance, predictive values, program yield, false positive burden, cost measures, calculator use, interpretation, reporting, and common mistakes. It is designed for public health programs, clinical screening pathways, occupational screening, and population-based early detection initiatives.

Table of Contents

1. Prerequisites and Background Concepts
2. What Is a Screening Program?
3. When Screening Is Appropriate
4. The Mathematics Behind Screening Evaluation
5. Assumptions, Benefits, and Harms
6. Using the Screening Program Calculator
7. Program Effectiveness Measures
8. Cost and Resource Measures
9. Worked Examples
10. Common Mistakes and How to Avoid Them
11. Troubleshooting
12. Quick Reference Cheat Sheet

1. Prerequisites and Background Concepts

1.1 Screening vs. Diagnosis

Screening is the systematic testing of people who do not already have a known disease diagnosis. A positive screen usually triggers confirmatory testing. Diagnosis is the clinical process of classifying disease in a person with symptoms, risk, or a positive screen.

1.2 Test Performance Table

1.3 Program-Level Thinking

A screening program is more than a test. It includes invitation, participation, testing, follow-up, diagnosis, treatment access, quality control, and monitoring.

2. What Is a Screening Program?

A screening program aims to detect disease earlier than it would otherwise be found, so that intervention improves outcomes.

The core question is:

Does screening this population produce enough benefit to justify the false positives, false negatives, costs, and follow-up workload?

3. When Screening Is Appropriate

Screening is most appropriate when:

• The condition is an important health problem.
• There is a detectable early stage.
• Earlier treatment improves outcomes.
• The screening test is acceptable and accurate enough.
• Confirmatory diagnosis and treatment are available.
• The program can be delivered equitably and continuously.
• Benefits outweigh harms and costs.

Screening is weaker when the disease is extremely rare, follow-up is unavailable, or false positives would create substantial harm.

4. The Mathematics Behind Screening Evaluation

4.1 Sensitivity and Specificity

$Sensitivity = \frac{TP}{TP + FN}$

$Specificity = \frac{TN}{TN + FP}$

4.2 Predictive Values

$PPV = \frac{TP}{TP + FP}$

$NPV = \frac{TN}{TN + FN}$

4.3 Prevalence-Based Expected Counts

For $N$ screened people and disease prevalence $P$:

$Diseased = N \times P$

$NonDiseased = N \times (1-P)$

$TP = Diseased \times Sensitivity$

$FN = Diseased \times (1-Sensitivity)$

$TN = NonDiseased \times Specificity$

$FP = NonDiseased \times (1-Specificity)$

4.4 Screening Yield

$Yield = \frac{Confirmed\ Cases\ Detected}{People\ Screened}$

4.5 Number Needed to Screen

$NNS = \frac{People\ Screened}{Confirmed\ Cases\ Detected}$

5. Assumptions, Benefits, and Harms

Screening evaluation assumes:

• Disease prevalence is estimated for the target population.
• Sensitivity and specificity are realistic for field conditions.
• Positive screens receive confirmatory follow-up.
• Treatment is available and effective.
• Participation rate is considered.
• Harms are included, not only detected cases.

Potential harms:

• False positives and anxiety.
• False negatives and false reassurance.
• Overdiagnosis.
• Overtreatment.
• Opportunity cost.
• Unequal access to follow-up care.

6. Using the Screening Program Calculator

Step-by-Step Guide

Step 1: Define the program.

Specify target population, disease, screening test, and time period.

Step 2: Enter population parameters.

Include target population size, expected prevalence, participation rate, and follow-up completion when available.

Step 3: Enter test performance.

Use sensitivity and specificity from credible validation studies in a similar population.

Step 4: Add program costs if evaluating resources.

Include test cost, confirmatory testing, administration, and follow-up costs when available.

Step 5: Review expected counts.

Inspect true positives, false positives, false negatives, and true negatives.

Step 6: Interpret program burden and benefit.

Look at yield, PPV, NNS, false positive burden, and cost per case detected.

7. Program Effectiveness Measures

7.1 Detection Rate

$Detection\ Rate = \frac{ScreenDetected\ Cases}{Total\ Screened} \times 1000$

7.2 Interval Case Rate

Interval cases occur between screening rounds:

$Interval\ Case\ Rate = \frac{Interval\ Cases}{Total\ Screened} \times 1000$

7.3 Program Sensitivity

$Program\ Sensitivity = \frac{ScreenDetected\ Cases}{ScreenDetected\ Cases + Interval\ Cases}$

Program sensitivity captures real-world performance, not just laboratory test accuracy.

7.4 Follow-Up Completion

$FollowUp\ Completion = \frac{Completed\ Diagnostic\ FollowUp}{Positive\ Screens}$

A screening program with poor follow-up may detect risk but fail to improve outcomes.

8. Cost and Resource Measures

8.1 Cost per Case Detected

$Cost\ per\ Case = \frac{Total\ Program\ Cost}{Confirmed\ Cases\ Detected}$

8.2 Cost per Life Year or QALY

When downstream outcome data are available:

$Cost\ per\ Life\ Year = \frac{Total\ Program\ Cost}{Life\ Years\ Saved}$

$Cost\ per\ QALY = \frac{Total\ Program\ Cost}{QALYs\ Gained}$

8.3 Capacity Planning

False positives drive follow-up workload:

$Expected\ False\ Positives = N(1-P)(1-Specificity)$

Even a highly specific test can create many follow-up visits in a low-prevalence population.

9. Worked Examples

Example 1: Low-Prevalence Population Screening

Inputs:

• $N = 10,000$
• Prevalence = 1%
• Sensitivity = 90%
• Specificity = 95%

Expected diseased:

$10,000 \times 0.01 = 100$

True positives:

$100 \times 0.90 = 90$

False negatives:

$100 \times 0.10 = 10$

False positives:

$9,900 \times 0.05 = 495$

PPV:

$PPV = 90/(90+495) = 15.4\%$

Interpretation: The program detects 90 true cases but generates 495 false positives. Follow-up capacity is central.

Example 2: Cost per Case Detected

If each screen costs $20 and 10,000 people are screened:

$Total\ Screening\ Cost = 10,000 \times 20 = 200,000$

With 90 detected cases:

$Cost\ per\ Case = 200,000/90 = 2,222.22$

This excludes confirmatory testing and treatment costs, so it is a partial cost measure.

10. Common Mistakes and How to Avoid Them

Mistake 1: Evaluating Screening by Sensitivity Alone

False positives, follow-up capacity, prevalence, and treatment availability matter.

Mistake 2: Ignoring Prevalence

Low prevalence can make PPV low even for good tests.

Mistake 3: Forgetting Follow-Up

A screening program fails if positive screens do not receive diagnostic confirmation.

Mistake 4: Calling Detection Benefit Without Outcome Evidence

More detected cases do not automatically mean fewer deaths or complications.

Mistake 5: Ignoring Overdiagnosis

Some detected cases may never have caused harm.

11. Troubleshooting

12. Quick Reference Cheat Sheet

Reporting Template

Screening [N] people with [test] is expected to detect [TP] true cases, miss [FN] cases, and generate [FP] false positives. The PPV is [value], NNS is [value], and cost per detected case is [value].

Final Checklist

• Define target population and disease.
• Use realistic prevalence.
• Enter sensitivity and specificity.
• Review false positive burden.
• Include participation and follow-up.
• Report yield and NNS.
• Discuss benefits, harms, and capacity.